mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
5e-06 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
6e-06 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-06 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-06 |